List of Purdue Pharma patents

Patents where

Current Assignee

Name

Purdue Pharma

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 9289397 Titratable dosage transdermal delivery system	Patent 9289397 was granted and assigned to Purdue Pharma on March, 2016 by the United States Patent and Trademark Office.	Purdue Pharma	Purdue Pharma	United States Patent and Trademark Office	9289397	March 22, 2016
‌ US Patent 8685071 Medical apparatus employing flexible light structures	Patent 8685071 was granted and assigned to Purdue Pharma on April, 2014 by the United States Patent and Trademark Office.		Purdue Pharma	United States Patent and Trademark Office	8685071	April 1, 2014
‌ US Patent 10013467 System and method for evaluating chemical entities using and applying a virtual landscape	Patent 10013467 was granted and assigned to Purdue Pharma on July, 2018 by the United States Patent and Trademark Office.	Purdue Pharma	Purdue Pharma	United States Patent and Trademark Office	10013467	July 3, 2018
‌ US Patent 9549903 Transdermal delivery system comprising buprenorphine	Patent 9549903 was granted and assigned to Purdue Pharma on January, 2017 by the United States Patent and Trademark Office.	Purdue Pharma	Purdue Pharma	United States Patent and Trademark Office	9549903	January 24, 2017
‌ US Patent 8685005 Light delivery system	Patent 8685005 was granted and assigned to Purdue Pharma on April, 2014 by the United States Patent and Trademark Office.		Purdue Pharma	United States Patent and Trademark Office	8685005	April 1, 2014
‌ US Patent 8195605 Data cache techniques in support of synchronization of databases in a distributed environment	Patent 8195605 was granted and assigned to Purdue Pharma on June, 2012 by the United States Patent and Trademark Office.		Purdue Pharma	United States Patent and Trademark Office	8195605	June 5, 2012
‌ US Patent 8143267 Analgesic combination of oxycodone and nimesulide	Patent 8143267 was granted and assigned to Purdue Pharma on March, 2012 by the United States Patent and Trademark Office.		Purdue Pharma	United States Patent and Trademark Office	8143267	March 27, 2012
‌ US Patent 9795681 Tamper resistant dosage form comprising an adsorbent and an adverse agent	Patent 9795681 was granted and assigned to Purdue Pharma on October, 2017 by the United States Patent and Trademark Office.	Purdue Pharma	Purdue Pharma	United States Patent and Trademark Office	9795681	October 24, 2017
‌ US Patent 8193209 Analgesic combination of oxycodone and meloxicam	Patent 8193209 was granted and assigned to Purdue Pharma on June, 2012 by the United States Patent and Trademark Office.		Purdue Pharma	United States Patent and Trademark Office	8193209	June 5, 2012
‌ US Patent 11494387 Chemical formula extrapolation and query building to identify source documents referencing relevant chemical formula moieties	Patent 11494387 was granted and assigned to Purdue Pharma on November, 2022 by the United States Patent and Trademark Office.	Purdue Pharma	Purdue Pharma	United States Patent and Trademark Office	11494387	November 8, 2022
‌ US Patent 7384653 Oral dosage form comprising a therapeutic agent and an adverse-effect agent	Patent 7384653 was granted and assigned to Purdue Pharma on June, 2008 by the United States Patent and Trademark Office.		Purdue Pharma	United States Patent and Trademark Office	7384653	June 10, 2008
‌ US Patent 8095213 Transdermal patch	Patent 8095213 was granted and assigned to Purdue Pharma on January, 2012 by the United States Patent and Trademark Office.		Purdue Pharma	United States Patent and Trademark Office	8095213	January 10, 2012
‌ US Patent 7842307 Pharmaceutical formulation containing opioid agonist, opioid antagonist and gelling agent	Patent 7842307 was granted and assigned to Purdue Pharma on November, 2010 by the United States Patent and Trademark Office.		Purdue Pharma	United States Patent and Trademark Office	7842307	November 30, 2010
‌ US Patent 9040084 Pharmaceutical formulation containing gelling agent	Patent 9040084 was granted and assigned to Purdue Pharma on May, 2015 by the United States Patent and Trademark Office.	Purdue Pharma	Purdue Pharma	United States Patent and Trademark Office	9040084	May 26, 2015
‌ US Patent 7070806 Controlled release formulations coated with aqueous dispersions of acrylic polymers	Patent 7070806 was granted and assigned to Purdue Pharma on July, 2006 by the United States Patent and Trademark Office.		Purdue Pharma	United States Patent and Trademark Office	7070806	July 4, 2006
‌ US Patent 9109007 MHC-I restricted epitopes containing non-natural amino acid residues	Patent 9109007 was granted and assigned to Purdue Pharma on August, 2015 by the United States Patent and Trademark Office.		Purdue Pharma	United States Patent and Trademark Office	9109007	August 18, 2015
‌ US Patent 7419686 Opioid agonist/antagonist combinations	Patent 7419686 was granted and assigned to Purdue Pharma on September, 2008 by the United States Patent and Trademark Office.		Purdue Pharma	United States Patent and Trademark Office	7419686	September 2, 2008
‌ US Patent 11590082 Encased tamper resistant controlled release dosage forms	Patent 11590082 was granted and assigned to Purdue Pharma on February, 2023 by the United States Patent and Trademark Office.	Purdue Pharma	Purdue Pharma	United States Patent and Trademark Office	11590082	February 28, 2023
‌ US Patent 9149651 Non-invasive vascular treatment systems, devices, and methods of using the same	Patent 9149651 was granted and assigned to Purdue Pharma on October, 2015 by the United States Patent and Trademark Office.		Purdue Pharma	United States Patent and Trademark Office	9149651	October 6, 2015
‌ US Patent 9861584 Tamper resistant controlled release dosage forms	Patent 9861584 was granted and assigned to Purdue Pharma on January, 2018 by the United States Patent and Trademark Office.	Purdue Pharma	Purdue Pharma	United States Patent and Trademark Office	9861584	January 9, 2018
‌ US Patent 9572779 Encased tamper resistant controlled release dosage forms	Patent 9572779 was granted and assigned to Purdue Pharma on February, 2017 by the United States Patent and Trademark Office.	Purdue Pharma	Purdue Pharma	United States Patent and Trademark Office	9572779	February 21, 2017
‌ US Patent 9744136 Encased tamper resistant controlled release dosage forms	Patent 9744136 was granted and assigned to Purdue Pharma on August, 2017 by the United States Patent and Trademark Office.	Purdue Pharma	Purdue Pharma	United States Patent and Trademark Office	9744136	August 29, 2017
‌ US Patent 10966932 Encased tamper resistant controlled release dosage forms	Patent 10966932 was granted and assigned to Purdue Pharma on April, 2021 by the United States Patent and Trademark Office.	Purdue Pharma	Purdue Pharma	United States Patent and Trademark Office	10966932	April 6, 2021
‌ US Patent 9872837 Tamper resistant controlled release dosage forms	Patent 9872837 was granted and assigned to Purdue Pharma on January, 2018 by the United States Patent and Trademark Office.	Purdue Pharma	Purdue Pharma	United States Patent and Trademark Office	9872837	January 23, 2018
‌ US Patent 9750703 Encased tamper resistant controlled release dosage forms	Patent 9750703 was granted and assigned to Purdue Pharma on September, 2017 by the United States Patent and Trademark Office.	Purdue Pharma	Purdue Pharma	United States Patent and Trademark Office	9750703	September 5, 2017

...

Results per page:

437 results

0 selected

437 results

0 selected